KR19990004221A - 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition - Google Patents

3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition Download PDF

Info

Publication number
KR19990004221A
KR19990004221A KR1019970028271A KR19970028271A KR19990004221A KR 19990004221 A KR19990004221 A KR 19990004221A KR 1019970028271 A KR1019970028271 A KR 1019970028271A KR 19970028271 A KR19970028271 A KR 19970028271A KR 19990004221 A KR19990004221 A KR 19990004221A
Authority
KR
South Korea
Prior art keywords
group
alkyl group
substituted
carbon atoms
nmr
Prior art date
Application number
KR1019970028271A
Other languages
Korean (ko)
Inventor
김인오
이상기
이소하
Original Assignee
박원훈
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박원훈, 한국과학기술연구원 filed Critical 박원훈
Priority to KR1019970028271A priority Critical patent/KR19990004221A/en
Publication of KR19990004221A publication Critical patent/KR19990004221A/en

Links

Abstract

본 발명은 다음 화학식 1을 갖는 3,4-디페닐부타노익산 유도체, 그 제조 방법 및 이를 유효 성분으로 하는 살균제 조성물에 관한 것이며,The present invention relates to a 3,4-diphenylbutanoic acid derivative having the following formula (1), a process for producing the same, and a fungicide composition containing the same as an active ingredient,

[화학식 1][Chemical Formula 1]

식 중, X는 할로겐 원소, 탄소 1~4개로 이루어진 알킬기, 메톡시기, 페녹시기 또는 브로모페닐기로 이루어진 군 중에서 선택된 것이며, Y는 탄소 1~4개로 이루어진 알킬기가 직접 치환되어 있거나, 탄소 1~4개로 이루어진 알킬기가 치환된 페닐기 또는 할로겐 원소(불소, 염소, 브롬 및 요오드)가 치환된 페닐기이다.Wherein X is selected from the group consisting of a halogen atom, an alkyl group of 1 to 4 carbon atoms, a methoxy group, a phenoxy group or a bromophenyl group, Y is an alkyl group of 1 to 4 carbon atoms, (Phenyl, chlorine, bromine and iodine) substituted phenyl group substituted by an alkyl group of 4 or substituted by a halogen element (fluorine, chlorine, bromine and iodine).

Description

3,4-치환 부타노익산 유도체, 그 제조 방법 및 그의 살균제 조성물3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition

본 발명은 새로운 알카노익산 유도체, 보다 상세하게는 다음의 화학식 1로 표시되는 3,4-치환 부타노익산 유도체 (Ⅰ)와 그 제조 방법 및 이를 유효 성분으로 하는 살균제 조성물에 관한 것으로서,The present invention relates to a novel alkanoic acid derivative, more specifically to a 3,4-substituted butanoic acid derivative (I) represented by the following general formula (I), a process for producing the same and a fungicide composition containing the same as an active ingredient.

[화학식 1][Chemical Formula 1]

식 중, X는 할로겐 원소, 탄소 1~4개로 이루어지는 알킬기, 메톡시기, 페녹시기 또는 브로모페닐기 등을 나타내며, Y는 탄소 1~4개로 이루어지는 알킬기가 직접 치환된 것이나 탄소 1~4개로 이루어지는 알킬기가 치환된 페닐기 또는 할로겐 원소가 치환된 페닐기를 나타낸다.Wherein X represents a halogen atom, an alkyl group of 1 to 4 carbon atoms, a methoxy group, a phenoxy group or a bromophenyl group, Y represents an alkyl group of 1 to 4 carbon atoms directly substituted with an alkyl group of 1 to 4 carbon atoms Represents a substituted phenyl group or a phenyl group substituted with a halogen atom.

다수의 알카노익산들이 항박테리아, 항균 항암 등의 생물 활성을 나타낸다고 보고되어 있다.[Chem. Pharm. Bull., 40(1993), 381~384, DE 2,635,664(1978)]. 보다 상세하게는, 알카노익산들은 전작, 후작 또는 논 등의 조건 하에서 사용할 수 있는 제초제로 개발되어 있고, 그 이외에도 몇몇 화합물들이 성장 조절제, 살충제 등으로 개발되어 상품화되어 있다. 예를 들면, 다음과 같은 알카노익산 유도체들이 상품화되어 있다.Many alkanoic acids have been reported to exhibit biological activities such as antibacterial and anticancer chemotherapy [Chem. Pharm. Bull., 40 (1993), 381-384, DE 2,635,664 (1978)]. More specifically, alkanoic acids have been developed as herbicides which can be used under conditions such as previous works, marquis or rice fields, and in addition, several compounds have been developed and commercialized as growth regulators, insecticides and the like. For example, the following alkanoic acid derivatives have been commercialized.

이 중에서, 클로르페낙(Chlorfenac; GBP 860,310)은 전작에 사용하는 제초제(2.8~3.4 ㎏/㏊)이며, 2,4-DB는 광엽 잡초에 효과적인 제초제이고, 다미노지드(Daminozide; USP 3,240799)는 성장 조절제, 4-인돌-3-일-부타노익산(4-Indol-3-yl-butyric acid; j. Van Overbeek, Encylopedia of Plant Physiology, 1996, 14, 1145)는 발근제, 클로람부실(Chlorambucil)은 살충제 등으로 사용되고 있다. 하지만, 3,4-치환된 부타노익산 유도체는 알려진 바가 없다.Among them, Chlorfenac (GBP 860,310) is a herbicide used in the previous works (2.8 to 3.4 kg / ㏊), 2,4-DB is an effective herbicide for light leaf weeds, Daminozide (USP 3, 240799) discloses a growth regulator, 4-Indol-3-yl-butyric acid (Van Overbeek, Encylopedia of Plant Physiology, 1996,14,1145) Chlorambucil is used as an insecticide. However, 3,4-substituted butanoic acid derivatives are not known.

많은 종류의 살균제, 살충제, 성장 조절제, 제초제 등이 농작물의 보호를 위하여 개발되어져 현재 사용되고 있다. 그러나, 이러한 약제의 장기 사용에 따른 균주의 내성 등으로 인하여, 그 효능이 시간이 지남에 따라 감소하기 때문에 생물 활성을 나타내는 새로운 선도 화합물의 발견을 위해 많은 연구가 수행되어지고 있다.Many kinds of fungicides, insecticides, growth regulators and herbicides have been developed for the protection of crops and are now being used. However, due to the resistance of the strain to the long-term use of such drugs, the efficacy thereof decreases over time, and thus many studies have been conducted to discover new lead compounds exhibiting biological activity.

이러한 문제점을 해결하기 위한 연구의 결과, 현재까지의 특허나 논문에 발표되어 있지 않은 새로운 화합물로서, 합성 방법이 간단하며, 다양한 형태로의 구조적 변화가 용이할 뿐만 아니라 높은 수율로 합성이 가능하고, 살균 활성을 갖는, 새로운 3,4-치환 부타노익산 유도체 (Ⅰ)을 합성할 수 있었다.As a result of research for solving these problems, it has been found that a novel compound which is not disclosed in patents or papers so far can be easily synthesized, can be easily changed into various forms and can be synthesized at a high yield, A novel 3,4-substituted butanoic acid derivative (I) having a fungicidal activity could be synthesized.

[반응식 1][Reaction Scheme 1]

화합물 (Ⅰ)의 제조 방법은 상기 반응식 1에 기술한 바와 같이, 아세틸클로라이드 유도체와 X 치환된 벤젠(Ⅱ)를 출발 물질로, 화합물(Ⅲ)과 화합물 (Ⅳ)를 합성하는 중간 단계를 거쳐 합성한다. 이를 보다 상세하게 설명하면, 다음과 같다.The compound (I) can be synthesized by an intermediate step of synthesizing the compound (III) and the compound (IV) starting from an acetyl chloride derivative and X-substituted benzene (II) do. This will be described in more detail as follows.

a) X 치환된 벤젠 (Ⅱ)를 디클로로메탄 또는 1,2-디클로로에탄 등의 용매에 녹이고 무수 염화알루미늄 등의 루이스산을 서서히 첨가한다. 0~5℃의 온도를 유지하며, 이 혼합물에 Y 치환된 아세틸클로라이드 유도체를 첨가한다. 이 반응 혼합물은 5~10 시간 상온에서 교반한 다음 5~10%의 황산 또는 염산 용액을 첨가한 후, 디클로로메탄 또는 1,2-디클로로에탄 등의 용매로 추출한다. 용매를 증류 제거한 후, 에탄올에서 재결정함으로써, 1차 중간체인 케톤 화합물 (Ⅲ)을 제조할 수 있다.a) X-substituted benzene (II) is dissolved in a solvent such as dichloromethane or 1,2-dichloroethane, and Lewis acid such as anhydrous aluminum chloride is slowly added. The Y-substituted acetyl chloride derivative is added to the mixture at a temperature of 0-5 ° C. The reaction mixture is stirred at room temperature for 5 to 10 hours, then added with a 5 to 10% sulfuric acid or hydrochloric acid solution, and then extracted with a solvent such as dichloromethane or 1,2-dichloroethane. The solvent is distilled off and recrystallized in ethanol to prepare the ketone compound (III) as the primary intermediate.

b) 아연 가루와 요오드 촉매 존재 하에서, 상기 일차 중간체 (Ⅲ)와 에틸 브로모아세테이트를 벤젠, 리그로인 또는 그 혼합 용매에서 온도 80~100℃로 5~8 시간 반응시킨 후, 10~15%의 황산 또는 염산 용액을 상온에서 첨가하여 반응을 종결시킨다. 유기층을 분리한 다음 용매를 제거한 후 잔류물을 재결정함으로써, 높은 수율의 2차 중간체 (Ⅳ)를 제조한다.b) reacting the primary intermediate (III) and ethyl bromoacetate in benzene, ligroin or a mixed solvent thereof at a temperature of 80 to 100 ° C for 5 to 8 hours in the presence of zinc powder and an iodine catalyst, Or a hydrochloric acid solution is added at room temperature to terminate the reaction. The organic layer is separated, the solvent is removed, and the residue is recrystallized to obtain a high-yield secondary intermediate (IV).

C) 상기 이차 중간체 화합물 (Ⅳ)를 디클로로메탄에 녹인 후, 당량 또는 약간 과량의 트리에틸실란과 무수 황산마그네슘을 첨가한다. 트리플루오르아세트산에 녹아 있는 BF3·Et2O상기 반응 용액에 반응 온도 0~5 ℃를 유지하면서 천천히 첨가한 후, 반응 온도를 0~5 ℃로 유지하며, 4~8 시간 동안 교반시킨다. 황산마그네슘을 여과하여 제거한 후, 용매와 트리플루오르아세트산을 감압(약 30mmHg) 하에서 증류 제거한다. 잔류물을 에틸알코올에 녹인 후 약 20~30%의 가성소다 또는 가성가리 염기 존재 하에서 약 4~6 시간 가열 환류시킨다. 반응 혼합물을 상온으로 냉각시킨 후, 염산 또는 황산을 이용하여 산성화한 다음 클로로포름 또는 디클로로메탄 용매로 추출한다. 추출된 유기층을 무수 황산마그네슘으로 건조한 후, 용매를 증류 제거한다. 잔류물을 헥산에서재결정함으로써 최종 화합물 3,4-치환된 부타노익산 유도체 (Ⅰ)을 제조하였다. 본 발명에 의한 3.4-치환된 부타노익산 유도체(I)도 은 시험관내 시험에서 벼도열병균에 대해서 탁월한 균사저지율을 보였으며 사과 탄저병균, 사과 부패병균, 사과 반점 낙엽병균 및 오이 흰가루병균 등에 대해서도 높은 활성을 나타내었다. 뿐만 아니라, 상기 화학식 1의 화합물 (Ⅰ)은 생체내 시험에서도 벼도열병균, 오이 흰가루병에 대해서도 높은 활성을 나타내었다.C) After dissolving the secondary intermediate compound (IV) in dichloromethane, an equivalent amount or a slight excess of triethylsilane and anhydrous magnesium sulfate is added. BF 3揃 Et 2 O dissolved in trifluoroacetic acid The reaction solution is added slowly to the above reaction solution while maintaining the reaction temperature at 0 to 5 ° C, and the reaction temperature is maintained at 0 to 5 ° C and stirred for 4 to 8 hours. After the magnesium sulfate was removed by filtration, the solvent and trifluoroacetic acid were distilled off under reduced pressure (about 30 mmHg). The residue is dissolved in ethyl alcohol and heated under reflux for about 4 to 6 hours in the presence of about 20 to 30% of caustic soda or parasitic base. The reaction mixture is cooled to room temperature, acidified with hydrochloric acid or sulfuric acid, and then extracted with chloroform or dichloromethane. The extracted organic layer is dried over anhydrous magnesium sulfate, and then the solvent is distilled off. The residue was recrystallized in hexane to give the final compound 3,4-substituted butanoic acid derivative (I). In the test in vitro, the 3.4-substituted butanoic acid derivative (I) according to the present invention showed excellent hyphal inhibition rate against rice blast fungus, and it was confirmed that the anthrax anthracnose, apple spoilage, apple spotted fungus and cucumber powdery mildew High activity. In addition, the compound (I) of the above formula (1) showed high activity against rice blast fungus and cucumber powdery mildew in in vivo test.

다음의 실시예에서 화합물 (Ⅲ), 화합물(Ⅳ) 및 화합물 (Ⅰ)의 제조 방법 및 활성 시험 방법을 보다 상세히 설명하고자 한다. 이 실시예는 본 발명을 예시하고자 하는 것이며 본 발명의 범위가 이에 한정되는 것을 의미하는 것은 아니다.In the following examples, methods for producing the compound (III), the compound (IV) and the compound (I) and the activity test method are described in more detail. This embodiment is intended to illustrate the present invention and does not limit the scope of the present invention.

(실시예)(Example)

A. 화합물 (Ⅲ)의 제조 방법A. Preparation of Compound (III)

실시예 1. 4-플루오르페닐벤질케톤Example 1. Preparation of 4-fluorophenylbenzyl ketone

무수염화알루미늄 23.5 g과 디클로로메탄 300 mL의 혼합물에 4-플루오르벤젠 15 mL를 온도 5℃를 유지하면서 천천히 첨가한 다음, 페닐아세틸클로라이드 29.3 mL를 2 시간에 걸쳐서 적가하였다. 이 반응 혼합물을 상온에서 10 시간 교반한 후, 10% 염산 수용액 500 mL를 첨가하여 유기층을 분리하였다. 분리된 유기층을 무수 황산마그네슘으로 건조·여과한 다음 여액을 감압 농축하고, 잔류물을 에틸알코올에서 재결정함으로써, 4-플루오르페닐벤질케톤을 26 g의 흰색 고체로 얻었다.To a mixture of 23.5 g of anhydrous aluminum chloride and 300 mL of dichloromethane, 15 mL of 4-fluorobenzene was slowly added while maintaining the temperature at 5 ° C, and then 29.3 mL of phenylacetyl chloride was added dropwise over 2 hours. The reaction mixture was stirred at room temperature for 10 hours, and then 500 mL of a 10% hydrochloric acid aqueous solution was added to separate the organic layer. The separated organic layer was dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was recrystallized in ethyl alcohol to give 26 g of 4-fluorophenylbenzyl ketone as a white solid.

수율: 78%, 재결정: 에탄올, 융점: 79~80 ℃,1H NMR(300 MHz, CDC13) δ 4.22(s, 2H), 7.08(t, J=8.31 Hz, 2H), 7.28(m, 5H), 8.01(dd, J=8.31 Hz, 2H);13C NMR(300 MHz, CDC13) δ 45.53, 115.77(d, J=21.8 HZ, C2-F), 127.17, 128.79, 130.54, 131.32, 133.10, 134.45, 165.66(d, J=225.11 Hz C1-F), 196.53; IR(KBr) 1688 ㎝-1.Yield: 78%, recrystallized from ethanol, melting point: 79 ~ 80 ℃, 1 H NMR (300 MHz, CDC1 3) δ 4.22 (s, 2H), 7.08 (t, J = 8.31 Hz, 2H), 7.28 (m, 5H), 8.01 (dd, J = 8.31 Hz, 2H); 13 C NMR (300 MHz, CDC1 3) δ 45.53, 115.77 (d, J = 21.8 HZ, C 2 -F), 127.17, 128.79, 130.54, 131.32, 133.10, 134.45, 165.66 (d, J = 225.11 Hz C 1 -F), 196.53; IR (KBr) 1688 cm -1 .

실시예 2. 4-브로모페닐벤질케톤Example 2. 4-Bromophenyl benzyl ketone

4-브로모벤젠과 페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.4-bromobenzene and phenylacetyl chloride in the same manner as in Example 1,

수율: 50%, 재결정: 에탄올, 융점: 111~112 ℃,1H NMR(300 MHz, CDC13) δ 4.22(s, 2H), 7.26(m, 5H), 7.56(d, J=8.52 Hz, 2H), 7.84(d, J=8.52 Hz, 2H);13C NMR(300 MHz, CDC13) δ 45.57, 127.09, 128.38, 128.81, 129.43, 130.16, 130.25, 132.01, 134.24, 135.39, 196.58Yield: 50%, recrystallized from ethanol, melting point: 111 ~ 112 ℃, 1 H NMR (300 MHz, CDC1 3) δ 4.22 (s, 2H), 7.26 (m, 5H), 7.56 (d, J = 8.52 Hz, 2H), 7.84 (d, J = 8.52 Hz, 2H); 13 C NMR (300 MHz, CDCl 3 ) 隆 45.57, 127.09, 128.38, 128.81, 129.43, 130.16, 130.25, 132.01, 134.24, 135.39, 196.58

실시예 3. 4-(4-브로모페닐페닐)벤질케톤Example 3. Synthesis of 4- (4-bromophenylphenyl) benzyl ketone

4-브로모바이페닐과 페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Was prepared from 4-bromobiphenyl and phenylacetyl chloride in the same manner as in Example 1,

수율: 85%, 재결정: 에탄올, 융점: 154~155 ℃,1H NMR(300 MHz, CDC13) δ 4.32(s, 2H), 7.33(m, 4H), 7.50(m, 3H), 7.65(m, 4H), 8.10(d, J=8.51 Hz, 2H);13C NMR(300 MHz, CDC13) δ 45.66, 122.75, 126.88, 127.11, 128.30, 128.67, 128.78, 129.01, 129.34, 132.16, 134.57, 135.65, 144.55, 197.13; IR(KBr) 1608(CO) ㎝-1.Yield: 85%, recrystallized from ethanol, melting point: 154 ~ 155 ℃, 1 H NMR (300 MHz, CDC1 3) δ 4.32 (s, 2H), 7.33 (m, 4H), 7.50 (m, 3H), 7.65 ( m, 4H), 8.10 (d, J = 8.51 Hz, 2H); 13 C NMR (300 MHz, CDCl 3 ) δ 45.66, 122.75, 126.88, 127.11, 128.30, 128.67, 128.78, 129.01, 129.34, 132.16, 134.57, 135.65, 144.55, 197.13; IR (KBr) 1608 (CO) cm -1 .

실시예 4. 4-메톡시페닐벤질케톤Example 4. 4-Methoxyphenyl benzyl ketone

아니졸(Anisole)과 페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Pyrimidin-2-one, anisole and phenylacetyl chloride.

수율: 66%, 재결정: 에탄올, 융점: 72~73 ℃,1H NMR(300 MHz, CDC13) δ 3.86(s, 2H), 4.25(s, 3H), 6.94(d, J=8.79 Hz, 2H), 7.30(m, 5H), 8.02(d, J=8.94Hz, 2H);13C NMR(300 MHz, CDC13) δ 45.28, 55.43, 113.91, 126.86, 128.72, 129.56, 129.71, 131.03, 163.64, 196.25; IR(KBr) 1690(CO) ㎝-1.Yield: 66%, recrystallized from ethanol, melting point: 72 ~ 73 ℃, 1 H NMR (300 MHz, CDC1 3) δ 3.86 (s, 2H), 4.25 (s, 3H), 6.94 (d, J = 8.79 Hz, 2H), 7.30 (m, 5H), 8.02 (d, J = 8.94 Hz, 2H); 13 C NMR (300 MHz, CDCl 3 ) 隆 45.28, 55.43, 113.91, 126.86, 128.72, 129.56, 129.71, 131.03, 163.64, 196.25; IR (KBr) 1690 (CO) cm -1 .

실시예 5. 4-페녹시페닐벤질케톤Example 5. 4-phenoxyphenyl benzyl ketone

페닐에테르와 페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 1, from phenyl ether and phenylacetyl chloride.

수율: 89%, 재결정: 에탄올, 융점: 92~93 ℃,1H NMR(300 MHz, CDC13) δ 4.16(s, 2H), 6.92(d, J=8.67 Hz, 2H), 7.00(d, J=7.74 Hz, 2H), 7.23(m, 7H), 7.94(d, J=8.58 Hz, 2H);13C NMR(300 MHz, CDC13) δ 45.48, 117.54, 120.40, 124.87, 127.01, 128.84, 129.63, 130.00, 130.56, 130.95, 131.33, 135.02, 155.56, 162.17, 196.19; IR(KBr) 1681(CO) ㎝-1.Yield: 89%, recrystallized from ethanol, melting point: 92 ~ 93 ℃, 1 H NMR (300 MHz, CDC1 3) δ 4.16 (s, 2H), 6.92 (d, J = 8.67 Hz, 2H), 7.00 (d, J = 7.74 Hz, 2H), 7.23 (m, 7H), 7.94 (d, J = 8.58 Hz, 2H); 13 C NMR (300 MHz, CDCl 3 ) 隆 45.48, 117.54, 120.40, 124.87, 127.01, 128.84, 129.63, 130.00, 130.56, 130.95, 131.33, 135.02, 155.56, 162.17, 196.19; IR (KBr) 1681 (CO) cm -1 .

실시예 6. 페닐에틸케톤Example 6. Synthesis of phenyl ethyl ketone

벤젠과 프로피오닐클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Benzene and propionyl chloride in the same manner as in Example 1,

수율: 99%, 융점: 액체,1H NMR(300 MHz, CDC13) δ 1.02(t, J=6.96 Hz, 3H), 2.84(s, 3H), 7.24~7.43(m, 2H), 7.87(d, J=7.2 Hz, 2H).Yield: 99%, melting point: liquid, 1 H NMR (300 MHz, CDC1 3) δ 1.02 (t, J = 6.96 Hz, 3H), 2.84 (s, 3H), 7.24 ~ 7.43 (m, 2H), 7.87 ( d, J = 7.2 Hz, 2H).

실시예 7. 3-(4-클로로페닐)에틸케톤Example 7. 3- (4-Chlorophenyl) ethyl ketone

4-클로로벤젠과 프로피오닐클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Was prepared from 4-chlorobenzene and propionyl chloride in the same manner as in Example 1,

수율: 90%, 융점: 33~33.5 ℃,1H NMR(300 MHz, CDC13) δ 1.21(t, J=7.32 Hz, 3H), 2.97(q, J=7.32 Hz, 2H), 7.40(d, J=4.41 Hz, 2H), 7.88(d, J=4.29 Hz, 2H).Yield: 90%, melting point: 33 ~ 33.5 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.21 (t, J = 7.32 Hz, 3H), 2.97 (q, J = 7.32 Hz, 2H), 7.40 (d , J = 4.41 Hz, 2H), 7.88 (d, J = 4.29 Hz, 2H).

실시예 8. 3-(4-메틸페닐)에틸케톤Example 8. Synthesis of 3- (4-methylphenyl) ethyl ketone

톨루엔과 프로피오닐클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Was prepared from toluene and propionyl chloride in the same manner as in Example 1,

수율: 50.3%, 융점: 액체(72~80 ℃/1.2 torr),1H NMR(300 MHz, CDC13) δ 1.02(t, J=7.08 Hz, 3H), 2.18(s, 3H), 2.73(q, J=7.08 Hz, 2h), 7.03(d, J=7.92 Hz, 2H), 7.67(d, J=8.52 Hz 2H).Yield: 50.3%, melting point: liquid (72 ~ 80 ℃ / 1.2 torr ), 1 H NMR (300 MHz, CDC1 3) δ 1.02 (t, J = 7.08 Hz, 3H), 2.18 (s, 3H), 2.73 ( q, J = 7.08 Hz, 2H), 7.03 (d, J = 7.92 Hz, 2H), 7.67 (d, J = 8.52 Hz 2H).

실시예 9. 3-(4-메톡시페닐)에틸케톤Example 9. Preparation of 3- (4-methoxyphenyl) ethyl ketone

아니졸과 프로피오닐클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Pyridin-2-yl-anisole and propionyl chloride.

수율: 72%, 융점: 23~23.5 ℃,1H NMR(300 MHz, CDC13) δ 1.23(t, J=7.32 Hz, 3H), 2.99(q, J=7.32 Hz, 2H), 3.86(s, 3H), 6.94(d,J=8.67 Hz, 2H), 7.96(d, J=8.79 Hz, 2H).Yield: 72%, melting point: 23 ~ 23.5 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.23 (t, J = 7.32 Hz, 3H), 2.99 (q, J = 7.32 Hz, 2H), 3.86 (s , 3H), 6.94 (d, J = 8.67 Hz, 2H), 7.96 (d, J = 8.79 Hz, 2H).

실시예 10. 3-(4-브로모페닐)에틸케톤Example 10. 3- (4-bromophenyl) ethyl ketone

4-브로모벤젠과 프로피오닐클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Was prepared from 4-bromobenzene and propionyl chloride in the same manner as in Example 1,

수율: 172%, 융점: 액체(100~120 ℃/1.25torr),1H NMR(300 MHz, CDC13) δ 1.16(t, J=7.2 Hz, 3H), 2.92(q, J=7.2 Hz, 2H), 7.54(d, J=8.19 Hz, 2H), 7.75(d, J=8.4 Hz, 2H).Yield: 172%; melting point: liquid (100 ~ 120 ℃ / 1.25torr) , 1 H NMR (300 MHz, CDC1 3) δ 1.16 (t, J = 7.2 Hz, 3H), 2.92 (q, J = 7.2 Hz, 2H), 7.54 (d, J = 8.19 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H).

실시예 11. 1-(4-페녹시페닐)-2(2-플루오르페닐)에타논Example 11 1- (4-phenoxyphenyl) -2 (2-fluorophenyl) ethanone

페닐에테르와 2-플루오르페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Phenyl ether and 2-fluorophenylacetyl chloride in the same manner as in Example 1,

수율: 88%, 재결정: 에탄올, 융점: 99~99.5 ℃,1H NMR(300 MHz, CDC13) δ 4.2(s, 2H), 6.88~7.98(m, 13H).Yield: 88%, recrystallization: ethanol, melting point: 99-99.5 캜, 1 H NMR (300 MHz, CDCl 3 ) δ 4.2 (s, 2H), 6.88-7.98 (m, 13H).

실시예 12. 1-(4-페녹시페닐)-2-(3-플루오르페닐)에타논Example 12. Preparation of 1- (4-phenoxyphenyl) -2- (3-fluorophenyl) ethanone

페닐에테르와 3-플루오르페닐아세틸클로라이드로부터, 상기 실시예 1과 같은 방법에 의해 제조하였다.Phenylethanol and 3-fluorophenylacetyl chloride in the same manner as in Example 1,

수율: 80%, 재결정: 에탄올, 융점: 56~56.5 ℃,1H NMR(300 MHz, CDC13) δ 4.20(s, 2H), 6.92~7.40(m, 11H), 7.98(d, 2H).Yield: 80%, recrystallization: ethanol, melting point: 56-56.5 캜, 1 H NMR (300 MHz, CDCl 3 ) 隆 4.20 (s, 2H), 6.92-7.40 (m, 11H), 7.98 (d, 2H).

실시예 13. 1-(4-페녹시페닐)-2-(4-플루오르페닐)에타논Example 13. Preparation of 1- (4-phenoxyphenyl) -2- (4-fluorophenyl) ethanone

페닐에테르와 4-플루오르페닐아세틸클로라이드로 부터, 상기 실시예 1과 같을 방법에 의해 제조하였다.Phenyl ether and 4-fluorophenylacetyl chloride by the same method as in Example 1, supra.

수율: 80%, 재결정: 에탄올, 융점: 85~85.5 ℃,1H NMR(300 MHz, CDC13) δ 4.15(s, 2H), 6.92~7.37(m, 11H), 7,95(d, 2H).Yield: 80%, recrystallized from ethanol, melting point: 85 ~ 85.5 ℃, 1 H NMR (300 MHz, CDC1 3) δ 4.15 (s, 2H), 6.92 ~ 7.37 (m, 11H), 7,95 (d, 2H ).

B. 화합물 (Ⅳ)의 제조 방법B. Preparation of compound (IV)

실시예 14, 에틸 3-(4-플루오르페닐)-3-히드록시-4-페닐부타노에이트Example 14 Ethyl 3- (4-fluorophenyl) -3-hydroxy-4-phenylbutanoate

벤젠, 또는 리그로인 벤젠 혼합 용매(1 : 1) 500 mL에 요오드 촉매량과 아연 가루 19.4 g을 첨가하고 1 시간 정도 환류시킨 후, 실온까지 냉각시켜 4-플루오르페닐벤질케톤 (실시예 1) 25.4g과 에틸 브로모아세테이트 10 mL를 반응 혼합물에 첨가하였다. 반응 혼합물을 서서히 환류시키면서 반응을 개시시킨 후, 나머지 에틸 브로모아세테이트 22.8 mL를 천천히 첨가하였다. 이 반응 혼합물을 8시간 환류시킨 후 실온으로 냉각시키고, 10~15% 황산 또는 염산 용액을 첨가하였다. 유기층을 분리시킨 다음, 무수 황산마그네슘으로 건조시켜, 여과하고 여액을 감압 농축시켜, 그 잔류물을 n-헥산에서 재결정하여 에틸 3-(4-플루오르페닐)-3-히드록시-4-페닐부타노에이트를 25 g의 흰색 고체로 얻었다.To 500 mL of a mixed solvent of benzene or ligroin benzene (1: 1), an iodine catalyst and 19.4 g of zinc powder were added and refluxed for about 1 hour and then cooled to room temperature to obtain 25.4 g of 4-fluorophenylbenzyl ketone (Example 1) 10 mL of ethyl bromoacetate was added to the reaction mixture. The reaction was initiated with gentle refluxing of the reaction mixture followed by the slow addition of 22.8 mL of the remaining ethyl bromoacetate. The reaction mixture was refluxed for 8 hours, then cooled to room temperature and 10-15% sulfuric acid or hydrochloric acid solution was added. The organic layer was separated, dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated under reduced pressure. The residue was recrystallized in n-hexane to obtain ethyl 3- (4-fluorophenyl) -3-hydroxy- The neat was obtained as 25 g of a white solid.

수율: 70%, 재결정: n-헥산, 융점: 57~58 ℃,1H NMR(300 MHz, CDC13) δ 1.11(t, J=7.14 Hz, 3H), 2.79(d, J=15.93 Hz, 1H), 3.03(d, J=13.59 Hz, 1H), 3.05,(d, J=15.93 Hz, 1H), 3.10(d, J=13.59 Hz, 1H), 4.03(q, J=7.14 Hz, 2H), 4.54(s, 1H), 7.01(m, 4H), 7,24(m, 3H), 7,35(m, 2H);13C NMR(300 MHz, CDC13) δ 14.02, 43.92, 50.07, 60.82, 75.17, 114.80(d, J=20.84 Hz), 126.70, 127.31, 127.93, 130.97, 136.38, 141.54, 161.94(d, J=245.22 Hz), 172.75; IR(KBr) 3474(OH), 1700(CO) ㎝-1.Yield: 70%, recrystallization: n- hexane, melting point: 57 ~ 58 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.11 (t, J = 7.14 Hz, 3H), 2.79 (d, J = 15.93 Hz, J = 13.59 Hz, 1 H), 3.03 (d, J = 13.59 Hz, 1 H), 3.05 (d, J = 15.93 Hz, ), 4.54 (s, 1H), 7.01 (m, 4H), 7.24 (m, 3H), 7.35 (m, 2H); 13 C NMR (300 MHz, CDC1 3) δ 14.02, 43.92, 50.07, 60.82, 75.17, 114.80 (d, J = 20.84 Hz), 126.70, 127.31, 127.93, 130.97, 136.38, 141.54, 161.94 (d, J = 245.22 Hz), 172.75; IR (KBr) 3474 (OH), 1700 (CO) cm -1 .

실시예 15. 에틸 3-(4-브로모페닐)-3-히드록시-4-페닐부타에이트Example 15 Ethyl 3- (4-bromophenyl) -3-hydroxy-4-phenylbutaate

4-브로모페닐벤질케톤 (실시예 2)을 출발물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 14 using 4-bromophenylbenzyl ketone (Example 2) as a starting material.

수율: 76%, 재결정: n-헥산, 융점: 65~66 ℃,1H NMR(300 MHz, CDC13) δ 1.13(t, J=7.13 Hz, 3H), 2.77(d, J=16.03 Hz, 1H), 3.00(d, J=12.60 Hz, 1H), 3.02,(d, J=16.03 Hz, 1H), 3.07(d, J=12.60 Hz, 1H), 4.03(q, J=7.13 Hz, 2H), 4.53(s, 1H), 7.04(m, 2H), 7.23(m, 5H), 7.30(m, 2H);13C NMR(300 MHz, CDC13) δ 14.07, 43.68, 49.85, 60.93, 75.18, 121.09, 126.76, 127.35, 127.96, 130.87, 130.95, 144.75, 172.65.Yield: 76%, recrystallization: n- hexane, melting point: 65 ~ 66 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.13 (t, J = 7.13 Hz, 3H), 2.77 (d, J = 16.03 Hz, J = 12.3 Hz, 1H), 3.00 (d, J = 12.60 Hz, 1H), 3.02 ), 4.53 (s, IH), 7.04 (m, 2H), 7.23 (m, 5H), 7.30 (m, 2H); 13 C NMR (300 MHz, CDCl 3 ) δ 14.07, 43.68, 49.85, 60.93, 75.18, 121.09, 126.76, 127.35, 127.96, 130.87, 130.95, 144.75, 172.65.

실시예 16. 에틸 3-4-(4-브로모페닐)페닐)-3-히드록시-4페닐부타노에이트Example 16. Preparation of ethyl 3-4- (4-bromophenyl) phenyl) -3-hydroxy-4-phenylbutanoate

4-(4-브로모페닐페닐)벤질케톤 (실시예 3)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 14, starting from 4- (4-bromophenylphenyl) benzyl ketone (Example 3) as a starting material.

수율: 85%, 재결정: n-헥산, 융점: 88~89 ℃,1H NMR(300 MHz, CDC13) δ 1.09(t, J=7.14 Hz, 3H), 2.80(d, J=15.95 Hz, 1H), 3.01(d, J=13.47 Hz, 1H), 3.05,(d, J=15.95 Hz, 1H), 3.11(d, J=13.47 Hz, 1H), 4.01(q, J=7.14 Hz, 2H), 4.47(s, 1H), 7.05(m, 2H), 7.21(m, 2H), 7.53(m, 8H);13C NMR(300 MHz, CDC13) δ 14.02, 43.78, 49.97, 60.75, 75.03, 121.51, 125.53, 126.53, 127.54, 128.54, 131.01, 132.01, 136.28, 138.04, 139.55, 145.03, 173.02; IR(KBr) 3445(OH), 1720(CO) ㎝-1.Yield: 85%, recrystallization: n- hexane, melting point: 88 ~ 89 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.09 (t, J = 7.14 Hz, 3H), 2.80 (d, J = 15.95 Hz, J = 13.47 Hz, 1H), 3.01 (d, J = 13.47 Hz, 1H), 3.05 (d, J = 15.95 Hz, ), 4.47 (s, IH), 7.05 (m, 2H), 7.21 (m, 2H), 7.53 (m, 8H); 13 C NMR (300 MHz, CDCl 3 ) 隆 14.02, 43.78, 49.97, 60.75, 75.03, 121.51, 125.53, 126.53, 127.54, 128.54, 131.01, 132.01, 136.28, 138.04, 139.55, 145.03, 173.02; IR (KBr) 3445 (OH), 1720 (CO) cm- 1 .

실시예 17. 에틸 3-(4-메톡시페닐)-3-히드록시-4-페닐부타노에이트Example 17. Preparation of ethyl 3- (4-methoxyphenyl) -3-hydroxy-4-phenylbutanoate

4-메톡시페닐벤질케톤 (실시예 4)을 출발 물질로 하여 상기 실시예 14와 같은 방법에 의해 제조하였다.4-methoxyphenylbenzyl ketone (Example 4) as a starting material.

수율: 94%, 재결정: n-헥산, 융점: 58~59 ℃,1H NMR(300 MHz, CDC13) δ 1.06(t, J=7.14 Hz, 3H), 2.75(d, J=15.81 Hz, 1H), 3.00(d, J=14.94 Hz, 1H), 3.02,(d, J=15.81 Hz, 1H), 3.03(d, J=14.94 Hz, 1H), 3.79(s, 3H), 4.00(q, J=7.14 Hz, 2H), 4.39(s, 1H), 6.82(d, J=8.79 Hz, 2H), 7.00(m, 2H), 7.23(m, 5H;13C NMR(300 MHz, CDC13) δ 14.05, 43.80, 50.17, 55.06, 60.72, 75.10, 113.49, 126.52, 127.82, 130,78, 130.97, 136.54, 137.64, 158,53, 172,85; IR(KBr) 3434(OH), 1702(CO) ㎝-1.Yield: 94%, recrystallization: n- hexane, melting point: 58 ~ 59 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.06 (t, J = 7.14 Hz, 3H), 2.75 (d, J = 15.81 Hz, 1H), 3.00 (d, J = 14.94 Hz, 1H), 3.02 (d, J = 15.81 Hz, 1H), 3.03 , J = 7.14 Hz, 2H) , 4.39 (s, 1H), 6.82 (d, J = 8.79 Hz, 2H), 7.00 (m, 2H), 7.23 (m, 5H; 13 C NMR (300 MHz, CDC1 3 IR (KBr) 3434 (OH), 1702 (CO), < RTI ID = 0.0 > ) Cm -1 .

실시예 18. 에틸 3-(4-페녹시페닐)-3-히드록시-4-페닐부타노에이트Example 18 Ethyl 3- (4-phenoxyphenyl) -3-hydroxy-4-phenylbutanoate

4-페녹시페닐벤질케톤 (실시예 5)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 14 using 4-phenoxyphenylbenzyl ketone (Example 5) as a starting material.

수율: 90%, 재결정: n-헥산, 융점: 78~79 ℃,1H NMR(300 MHz, CDC13) δ 1.13(t, J=7.14 Hz, 3H), 2.77(d, J=15.90 Hz, 1H), 3.01(d, J=13.47 Hz, 2H), 3.04,(d, J=15.90 Hz, 1H), 3.10(d, J=13.47 Hz, 1H), 4.01(q, J=7.14 Hz, 2H), 4.47(s, 1H), 6.91~7.44(m, 14H);13C NMR(300 MHz, CDC13) δ 14.07, 43.81, 50.10, 60.78, 75.16, 118.37, 118.68, 123.18, 126.70, 126.84, 127.83, 12972, 130.84, 136.37, 140.43, 154.78, 172.79; IR(KBr) 3455(OH), 1710(CO) ㎝-1.Yield: 90%, recrystallization: n- hexane, melting point: 78 ~ 79 ℃, 1 H NMR (300 MHz, CDC1 3) δ 1.13 (t, J = 7.14 Hz, 3H), 2.77 (d, J = 15.90 Hz, J = 13.47 Hz, 2H), 3.01 (d, J = 13.47 Hz, 1H), 3.01 ), 4.47 (s, 1 H), 6.91-7.44 (m, 14H); 13 C NMR (300 MHz, CDCl 3 ) δ 14.07, 43.81, 50.10, 60.78, 75.16, 118.37, 118.68, 123.18, 126.70, 126.84, 127.83, 12972, 130.84, 136.37, 140.43, 154.78, 172.79; IR (KBr) 3455 (OH), 1710 (CO) cm -1 .

실시예 19. 3-폐닐-3-히드록시펜타노익산Example 19. 3-Ethyl-3-hydroxypentanoic acid

페닐에틸케톤 (실시예 6)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.The title compound was prepared by the same method as in Example 14, using phenylethylketone (Example 6) as a starting material.

수율: 29%, 융점:1H NMR(300 MHz, CDC13) δ 0.74(t, J=7.44 Hz, 3H), 1.01(t, J=7.08 Hz, 3H), 1.77(m, 2H), 2.78(d, J=25.93 Hz, 1H), 2.95,(d, J=15.93 Hz, 1H), 3.94(q, J=7.08 Hz, 2H), 4.30(s, 1H), 7.13~7.40(m, 5H.Yield: 29%, melting point: 1 H NMR (300 MHz, CDC1 3) δ 0.74 (t, J = 7.44 Hz, 3H), 1.01 (t, J = 7.08 Hz, 3H), 1.77 (m, 2H), 2.78 (d, J = 25.93 Hz, 1H), 2.95, (d, J = 15.93 Hz, 1H), 3.94 (q, J = 7.08 Hz, 2H), 4.30 .

실시예 20. 3-(4-클로로페닐)-3-히드록시펜타노익산Example 20. Preparation of 3- (4-chlorophenyl) -3-hydroxypentanoic acid

3-(4-클로포페닐)에틸케톤 (실시예 7)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 14 using 3- (4-chlorophenyl) ethyl ketone (Example 7) as a starting material.

수율: 70%, 융점: 액체,1H NMR(300 MHz, CDC13) δ 0.73(t, J=7.2 Hz, 3H), 1.08(t, J=7.14 Hz, 3H), 1.76(m, 2H), 2.78(d, J=15.93 Hz, 1H), 2.93,(s, J=15.93 Hz, 1H), 4.01(q, J=7.32 Hz, 2H), 4.40(s, 1H), 7.27(d, J=8.52 Hz, 2H), 7.34(d, J=8.79 Hz, 2H).Yield: 70%, melting point: liquid, 1 H NMR (300 MHz, CDC1 3) δ 0.73 (t, J = 7.2 Hz, 3H), 1.08 (t, J = 7.14 Hz, 3H), 1.76 (m, 2H) , 2.78 (d, J = 15.93 Hz, 1 H), 2.93 (s, J = 15.93 Hz, 1 H), 4.01 = 8.52 Hz, 2H), 7.34 (d, J = 8.79 Hz, 2H).

실시예 21. 3-(4-메틸페닐)-3-히드록시펜타노익산Example 21. Synthesis of 3- (4-methylphenyl) -3-hydroxypentanoic acid

3-(4-메틸페닐)에틸케톤 (실시예 8)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 14 using 3- (4-methylphenyl) ethyl ketone (Example 8) as a starting material.

수율: 71%, 융점: 액체,1H NMR(300 MHz, CDC13) δ 0.74(t, J=7.52 Hz, 3H), 1.06(t, J=7.08 Hz, 3H), 1.75(m, 2H), 2.28,(s, 3H), 2.76(d, J=15.99 Hz, 1H), 2.94(d, J=15.99 Hz, 1H), 3.97(q, J=7.08 Hz 2H), 4.25(s, 1H), 7,10(d, J=8.07 Hz, 2H), 7.27(d, J=8.55 Hz, 2H).Yield: 71%, melting point: liquid, 1 H NMR (300 MHz, CDC1 3) δ 0.74 (t, J = 7.52 Hz, 3H), 1.06 (t, J = 7.08 Hz, 3H), 1.75 (m, 2H) (S, 3H), 2.76 (d, J = 15.99 Hz, 1H), 2.94 (d, J = 15.99 Hz, 1H), 3.97 , 7.10 (d, J = 8.07 Hz, 2H), 7.27 (d, J = 8.55 Hz, 2H).

실시예 22. 3-(4-메톡시페닐)-3-히드록시펜타노익산Example 22. Preparation of 3- (4-methoxyphenyl) -3-hydroxypentanoic acid

3-(4-메톡시페닐)에틸케톤 (실시예 9)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 14, using 3- (4-methoxyphenyl) ethyl ketone (Example 9) as a starting material.

수율: 43%, 융점: 액체,1H NMR(300 MHz, CDC13) δ 0.75(t, J=7.44 Hz, 3H), 1.08(t, J=7.32 Hz, 3H), 1.76(m, 2H), 2.76,(d, J=15.57 Hz, 1H), 2.93(d, J=15.57 Hz, 1H), 3.76(s, 3H), 3.99(q, J=7.44 Hz 2H), 4.33(s, 1H), 6.84(d, J=8.67 Hz, 2H), 7.32(d, J=8.67 Hz, 2H).Yield: 43%, melting point: liquid, 1 H NMR (300 MHz, CDC1 3) δ 0.75 (t, J = 7.44 Hz, 3H), 1.08 (t, J = 7.32 Hz, 3H), 1.76 (m, 2H) , 2.76 (d, J = 15.57 Hz, 1 H), 2.93 (d, J = 15.57 Hz, 1 H), 3.76 , 6.84 (d, J = 8.67 Hz, 2H), 7.32 (d, J = 8.67 Hz, 2H).

실시예 23. 3-(4-브로모페닐)-3-히드록시펜타노익산Example 23. Preparation of 3- (4-bromophenyl) -3-hydroxypentanoic acid

3-(4-브로모페닐)에틸케톤 (실시예 10)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 14, using 3- (4-bromophenyl) ethyl ketone (Example 10) as a starting material.

수율: 84%, 융점: 액체,1H NMR(300 MHz, CDC13) δ 0.68(t, J=7.44 Hz, 3H), 1.02(t, J=7.2 Hz, 3H), 1.71(m, 2H), 2.73,(d, J=15.69 Hz, 1H), 2.87(d, J=15.69 Hz, 1H), 3.95(q, J=7.2 Hz 2H), 4.36(s, 1H), 7.21~7.39(m, 4H).Yield: 84%, melting point: liquid, 1 H NMR (300 MHz, CDC1 3) δ 0.68 (t, J = 7.44 Hz, 3H), 1.02 (t, J = 7.2 Hz, 3H), 1.71 (m, 2H) , 2.73 (d, J = 15.69 Hz, 1H), 2.87 (d, J = 15.69 Hz, 1H), 3.95 (q, J = 7.2 Hz 2H), 4.36 4H).

실시예 24.에틸 3-(4-페녹시페닐)-3-히드록시-4-(2-플루오르페닐)부타노에이트Example 24. Preparation of ethyl 3- (4-phenoxyphenyl) -3-hydroxy-4- (2-fluorophenyl) butanoate

1-(4-페녹시페닐)-(2-플루오르페닐)에타논 (실시예 11)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 14, starting with 1- (4-phenoxyphenyl) - (2-fluorophenyl) ethanone (Example 11) as a starting material.

수율: 90%,1H NMR(300 MHz, CDC13) δ 1.11(t, J=7.44 Hz, 3H), 2.76(t, J=15.7 Hz, 1H), 3.00(d, J=13.00 Hz, 2H), 3.03(d, J=15.7 Hz, 1H), 3.09(d, J=13.00 Hz, 1H), 4.00(q, J=7.2 Hz 2H), 4.46(s, 1H), 6.90~7.40(m, 14H). Yield: 90%, 1 H NMR ( 300 MHz, CDC1 3) δ 1.11 (t, J = 7.44 Hz, 3H), 2.76 (t, J = 15.7 Hz, 1H), 3.00 (d, J = 13.00 Hz, 2H 1H), 3.03 (d, J = 15.7 Hz, 1H), 3.09 (d, J = 13.00 Hz, 1H), 4.00 14H).

실시예 25. 에틸 3-(4-페녹시페닐)-3-히드록시-4-(3-플루오르페닐)부타노에이트Example 25. Preparation of ethyl 3- (4-phenoxyphenyl) -3-hydroxy-4- (3-fluorophenyl) butanoate

1-(4-페녹시페닐)-2-(3-플루오르페닐)에타논 (실시예 12)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 14, starting from 1- (4-phenoxyphenyl) -2- (3-fluorophenyl) ethanone (Example 12) as a starting material.

수율: 95%,1H NMR(300 MHz, CDC13) δ 1.10(t, J=7.2 Hz, 3H), 2.76(d, J=15.6 Hz, 1H), 3.01(d, J=12.99 Hz, 2H), 3.02(d, J=15.8 Hz, 1H), 3.07(d, J=12.9 Hz, 1H), 4.02(q, J=7.2 Hz 2H), 4.45(s, 1H), 6.91~7.38(m, 14H).Yield: 95%, 1 H NMR (300 MHz, CDCl 3 )? 1.10 (t, J = 7.2 Hz, 3H), 2.76 1H), 3.02 (d, J = 15.8 Hz, 1H), 3.07 (d, J = 14H).

실시예 26. 에틸 3-(4-페녹시페닐)-3-히드록시-4-(4-플루오르페닐)부타노에이트Example 26. Ethyl 3- (4-phenoxyphenyl) -3-hydroxy-4- (4-fluorophenyl) butanoate

1-(4-페녹시페닐)-2-(4-플루오르페닐)에타논 (실시예 13)을 출발 물질로 하여, 상기 실시예 14와 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 14, starting from 1- (4-phenoxyphenyl) -2- (4-fluorophenyl) ethanone (Example 13) as a starting material.

수율: 91%,1H NMR(300 MHz, CDC13) δ 1.11(t, J=7.2 Hz, 3H), 2.75(d, J=15.5 Hz, 1H), 3.03(d, J=12.88 Hz, 2H), 3.05(d, J=15.6 Hz, 1H), 3.10(d, J=12.6 Hz, 1H), 4.05(q, J=7.2 Hz 2H), 4.47(s, 1H), 6.93~7.40(m, 14H). Yield: 91%, 1 H NMR ( 300 MHz, CDC1 3) δ 1.11 (t, J = 7.2 Hz, 3H), 2.75 (d, J = 15.5 Hz, 1H), 3.03 (d, J = 12.88 Hz, 2H 1H), 3.05 (d, J = 15.6 Hz, 1H), 3.10 (d, J = 14H).

C. 화합물 (Ⅰ)의 합성C. Synthesis of Compound (I)

실시예 27. 3-(4-플루오르페닐)-4-페닐부타노익산(1)Example 27. 3- (4-Fluorophenyl) -4-phenylbutanoic acid (1)

디클로로메탄 70 mL에 무수 황산마그네슘 1.8 g, 트리에틸실란 5.1 mL 및 에틸 3-(4-플루오르페닐)-3-히드록시-4-부터노에이트 (실시에 14) 8g을 첨가하여 교반시키면서, 트리플루오르아세트산 16.1 mL와 BF3·Et2O 0.34 mL의 혼합 용액을 천천히 첨가하고, 4 시간 동안 5 ℃ 이하의 온도에서 교반시키면서 반응시켰다. 반응 완결후 무수 황산나트륨을 여과해내고, 용매와 트리플루오르아세트산을 감압 하에서 증류하여 제거하였다. 잔류물을 20mL의 에탄올을 녹인 후, KOH 또는 NaOH의 30% 수용액 20㎖를 넣고 5시간 동안 환류하여 반응시킨후 에탄올을 감압하에서 제거하고 10% 염산 수용액으로 산성화한 후, 디클로로메탄으로 반응 생성물을 추출하였다. 이 유기층을 무수 황산 나트륨으로 건조한 후, 감압 하에서 유기 용매 를 제거하고, 잔류물을 n-헥산으로 재결정하여 3-(4-플루오르페닐)-4-부타노익산 4.5 g을 얻었다.1.8 g of anhydrous magnesium sulfate, 5.1 mL of triethylsilane and 8 g of ethyl 3- (4-fluorophenyl) -3-hydroxy-4-nonoate (Example 14) were added to 70 mL of dichloromethane, A mixed solution of 16.1 mL of fluoroacetic acid and 0.34 mL of BF 3 .Et 2 O was added slowly and reacted for 4 hours at a temperature of 5 ° C or lower while stirring. After completion of the reaction, anhydrous sodium sulfate was filtered out, and the solvent and trifluoroacetic acid were distilled off under reduced pressure. The residue was dissolved in 20 mL of ethanol, 20 mL of a 30% aqueous solution of KOH or NaOH was added, and the mixture was refluxed for 5 hours. After the reaction was completed, the ethanol was removed under reduced pressure and acidified with a 10% aqueous hydrochloric acid solution. And extracted. The organic layer was dried over anhydrous sodium sulfate, and the organic solvent was removed under reduced pressure. The residue was recrystallized from n-hexane to obtain 4.5 g of 3- (4-fluorophenyl) -4-butanoic acid.

수율: 66%, 재결정: n-헥산, 융점: 110~111 ℃,1H NMR(300 MHz, CDC13) δ 2.60(m, 2H), 2.85(m, 2H), 3.40(m, 1H), 6.96~7.42(m, 9H), 10.93(s, 1H);13C NMR(300 MHz, CDC13) δ 40.13, 43.02, 43.13, 115.32(d, J=20.76 Hz), 126.44, 127.57, 128.65, 139.14, 158.78, 161.69(d, J=244.54 Hz), 178.54; IR(KBr) 3028(OH), 1704(CO) ㎝-1.Yield: 66%, recrystallization: n- hexane, melting point: 110 ~ 111 ℃, 1 H NMR (300 MHz, CDC1 3) δ 2.60 (m, 2H), 2.85 (m, 2H), 3.40 (m, 1H), 6.96-7.42 (m, 9H), 10.93 (s, 1 H); 13 C NMR (300 MHz, CDCl 3 ) δ 40.13, 43.02, 43.13, 115.32 (d, J = 20.76 Hz), 126.44,127.57,128.65,139.14,158.78,161.69 (d, J = 244.54 Hz), 178.54. IR (KBr) 3028 (OH), 1704 (CO) cm -1 .

실시예 28. 3-(4-브로모페닐)-4페닐부타노익산(2)Example 28. 3- (4-bromophenyl) -4-phenylbutanoic acid (2)

에틸 3-(4-브로모페닐)-3-히드록시-4페닐부타노에이트 (실시예 15)로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from ethyl 3- (4-bromophenyl) -3-hydroxy-4-phenylbutanoate (Example 15).

수율: 85%, 재결정: n-헥산, 융점: 139~140 ℃,1H NMR(300 MHz, CDC13) δ 2.65(m, 2H), 2.87(m, 2H), 3.36(tt, J=7.44, 7.44 Hz, 1H), 6.91~7.44(m, 9H);13C NMR(300 MHz, CDC13) δ 39.40, 42.82, 43.17, 120.49, 126.40, 128.34, 129.22, 131.55, 138.86, 142.08, 176.60; IR(KBr) 3010(OH), 1700(CO) ㎝-1.Yield: 85%, recrystallization: n- hexane, melting point: 139 ~ 140 ℃, 1 H NMR (300 MHz, CDC1 3) δ 2.65 (m, 2H), 2.87 (m, 2H), 3.36 (tt, J = 7.44 , 7.44 Hz, 1 H), 6.91-7.44 (m, 9H); 13 C NMR (300 MHz, CDCl 3 ) 隆 39.40, 42.82, 43.17, 120.49, 126.40, 128.34, 129.22, 131.55, 138.86, 142.08, 176.60; IR (KBr) 3010 (OH), 1700 (CO) cm -1 .

실시예 29. 3-(4-(4-브로모페닐)페닐)-4-4페닐부타노익산(3)Example 29. 3- (4- (4-bromophenyl) phenyl) -4-4 phenylbutanoic acid (3)

에틸 3-(4-(4-브로모페닐)페닐)-3-히도록시-4-페닐부타노에이트 (실시예 16)로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.4-phenylbutanoate (Example 16) was prepared in the same manner as in Example 27, from ethyl 3- (4- (4-bromophenyl) phenyl)

수율: 86%, 재결정: n-헥산, 융점: 115~116 ℃,1H NMR(300 MHz, CDC13) δ 2.62(m, 2H), 2.92(m, 2H), 3.43(m, 1H), 7.01~7.63(m,13H);13C NMR(300 MHz, CDC13) δ 40.12, 42.92, 43.34, 126.32, 126.87, 127.07, 128.00, 128.11, 128.32, 128.57, 129.26, 139.30, 142.90, 178.45; IR(KBr) 3027(OH), 1706(CO) ㎝-1.Yield: 86%, recrystallization: n- hexane, melting point: 115 ~ 116 ℃, 1 H NMR (300 MHz, CDC1 3) δ 2.62 (m, 2H), 2.92 (m, 2H), 3.43 (m, 1H), 7.01-7.63 (m, 13H); 13 C NMR (300 MHz, CDCl 3 ) δ 40.12, 42.92, 43.34, 126.32, 126.87, 127.07, 128.00, 128.11, 128.32, 128.57, 129.26, 139.30, 142.90, 178.45; IR (KBr) 3027 (OH), 1706 (CO) cm -1 .

실시예 30. 3-(4-메톡시페닐)-4-페닐부타노익산(4)Example 30. 3- (4-methoxyphenyl) -4-phenylbutanoic acid (4)

에틸 3-(4-메톡시페닐)-3-히도록시-4-페닐부타노에이트 (실시예 17)로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 27 from ethyl 3- (4-methoxyphenyl) -3-hygioxy-4-phenylbutanoate (Example 17).

수율: 92%, 재결정: 에탄올, 융점: 125~126 ℃,1H NMR(300 MHz, CDC13) δ 2.63(m, 2H), 2.87(d, J=5.49 Hz, 2H), 3.35(m, 1H), 3.77(s, 3H), 7.04(m, 2H), 7.10(m, 7H), 10.80(s, 1H);13C NMR(300 MHz, CDC13) δ 39.96, 42.88, 43.21, 55.16, 113.96, 126.29, 128.32, 128.49, 129.33, 135.28, 139.55, 158.32, 178.89; IR(KBr) 3027(OH), 1711(CO) ㎝-1.Yield: 92%, recrystallized from ethanol, melting point: 125 ~ 126 ℃, 1 H NMR (300 MHz, CDC1 3) δ 2.63 (m, 2H), 2.87 (d, J = 5.49 Hz, 2H), 3.35 (m, 1H), 3.77 (s, 3H), 7.04 (m, 2H), 7.10 (m, 7H), 10.80 (s, 1H); 13 C NMR (300 MHz, CDCl 3 ) 隆 39.96, 42.88, 43.21, 55.16, 113.96, 126.29, 128.32, 128.49, 129.33, 135.28, 139.55, 158.32, 178.89; IR (KBr) 3027 (OH), 1711 (CO) cm -1 .

실시예 31. 3-(4-메톡시페닐)-4-페닐부타노익산(5)Example 31. 3- (4-methoxyphenyl) -4-phenylbutanoic acid (5)

에틸 3-(4-메톡시페닐)-3-히도록시-4-페닐부타노에이트 (실시예 18)로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 27 from ethyl 3- (4-methoxyphenyl) -3-hygioxy-4-phenylbutanoate (Example 18).

수율: 71%, 재결정: n-헥산과 벤젠의 혼합 용매; 융점: 110~111 ℃;1H NMR(300 MHz, CDC13) δ 2.67(m, 2H), 2.95(d, J=7.44 Hz, 2H), 3.43(tt, J=7.40, 7.40 Hz, 1H), 6.93~7.40(m, 14H);13C NMR(300 MHz, CDC13) δ 39.92, 43.12, 118.72, 118.89, 123.13, 126.33, 128.75, 129.30, 129.83, 138.04, 139.28, 155.82; IR(KBr) 3046(OH), 1701(CO) ㎝-1.Yield: 71%, recrystallization: mixed solvent of n-hexane and benzene; Melting point: 110-111 DEG C; 1 H NMR (300 MHz, CDC1 3) δ 2.67 (m, 2H), 2.95 (d, J = 7.44 Hz, 2H), 3.43 (tt, J = 7.40, 7.40 Hz, 1H), 6.93 ~ 7.40 (m, 14H); 13 C NMR (300 MHz, CDCl 3 ) 隆 39.92, 43.12, 118.72, 118.89, 123.13, 126.33, 128.75, 129.30, 129.83, 138.04, 139.28, 155.82; IR (KBr) 3046 (OH), 1701 (CO) cm -1 .

실시예 32. 3-페닐펜타노익산(6)Example 32. 3-Phenylpentanoic acid (6)

3-페닐-3-히드록시펜타노익산 (실시예 19)으로부터 상기 실시예 27과 같은 방법에 의해 제조하였다.Was prepared from 3-phenyl-3-hydroxypentanoic acid (Example 19) in the same manner as in Example 27.

수율: 91%, 재결정: 액체;1H NMR(300 MHz, CDC13) δ 0.75(t, J=7.2 Hz, 3H), 1.62(m, 2H), 1.71(m, 1H), 2.60(m, 2H), 2.96(m, 1H), 7.12~7.34(m, 5H), 10,68(s, 1H).Yield: 91%, recrystallization: liquid; 1 H NMR (300 MHz, CDC1 3) δ 0.75 (t, J = 7.2 Hz, 3H), 1.62 (m, 2H), 1.71 (m, 1H), 2.60 (m, 2H), 2.96 (m, 1H) , 7.12-7.34 (m, 5H), 10.68 (s, 1H).

실시예 33. 3-(4-클로로페닐)펜타노익산(7)Example 33. 3- (4-Chlorophenyl) pentanoic acid (7)

3-(4-클로로페닐)-3-히드록시펜타노익산 (실시예 20)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from 3- (4-chlorophenyl) -3-hydroxypentanoic acid (Example 20).

수율: 90%, 융점: 66~66.5 ℃;1H NMR(300 MHz, CDC13) δ 0.75(t, J=7.58 Hz, 3H), 1.62(m, 1H), 1.71(m, 1H), 2.62(m, 2H), 2.96(m, 1H), 7.06(d, 2H), 7.25(d, 2H).Yield: 90%, melting point: 66-66.5 캜; 1 H NMR (300 MHz, CDC1 3) δ 0.75 (t, J = 7.58 Hz, 3H), 1.62 (m, 1H), 1.71 (m, 1H), 2.62 (m, 2H), 2.96 (m, 1H) , 7.06 (d, 2H), 7.25 (d, 2H).

실시예 34. 3-(4-메틸페닐)펜타노익산(8)Example 34. 3- (4-Methylphenyl) pentanoic acid (8)

3-(4-메틸페닐)-3-히드록시펜타노익산 (실시예 21)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from 3- (4-methylphenyl) -3-hydroxypentanoic acid (Example 21).

수율: 88%, 융점: 49~49.5 ℃;1H NMR(300 MHz, CDC13) δ 0.77(t, J=7.32 Hz, 3H), 1.54(m, 1H), 1.72(m, 1H), 2.30(s, 3H), 2.57(m, 2H), 2.94(m, 1H), 7.10(m, 5H).Yield: 88%, melting point: 49-49.5 캜; 1 H NMR (300 MHz, CDC1 3) δ 0.77 (t, J = 7.32 Hz, 3H), 1.54 (m, 1H), 1.72 (m, 1H), 2.30 (s, 3H), 2.57 (m, 2H) , 2.94 (m, 1 H), 7.10 (m, 5 H).

실시예 35. 3-(4-메톡시페닐)펜타노익산(9)Example 35. 3- (4-Methoxyphenyl) pentanoic acid (9)

3-(4-메톡시페닐)-3-히드록시펜타노익산 (실시예 22)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from 3- (4-methoxyphenyl) -3-hydroxypentanoic acid (Example 22).

수율: 86%, 융점: 79~79.5 ℃;1H NMR(300 MHz, CDC13) δ 0.77(t, J=7.20 Hz, 3H), 1.58(m, 1H), 1.69(m, 1H), 2.64(m, 2H), 2.93(m, 1H), 3.76(s, 3H),6.84(d, 2H), 7.09(d, 2H), 11.20(s, 1H).Yield: 86%, melting point: 79-79.5 DEG C; 1 H NMR (300 MHz, CDC1 3) δ 0.77 (t, J = 7.20 Hz, 3H), 1.58 (m, 1H), 1.69 (m, 1H), 2.64 (m, 2H), 2.93 (m, 1H) , 3.76 (s, 3H), 6.84 (d, 2H), 7.09 (d, 2H), 11.20 (s, 1H).

실시예 36. 3-(4-브로모페닐)펜타노익산(10)Example 36. 3- (4-Bromophenyl) pentanoic acid (10)

3-(4-브로모페닐)-3-히드록시펜타노익산 (실시예 23)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from 3- (4-bromophenyl) -3-hydroxypentanoic acid (Example 23).

수율: 82%; 융점: 69~69.5 ℃;1H NMR(300 MHz, CDC13) δ 0.75(t, J=7.38 Hz, 3H), 1.57(m, 1H), 1.69(m, 1H), 2.55(s, 2H), 2.93(m, 1H), 7.04(d, J=8.4 Hz, 2H), 7.41(d, J=8.0 Hz, 2H), 11.50(s, 1H).Yield: 82%; Melting point: 69-69.5 DEG C; 1 H NMR (300 MHz, CDC1 3) δ 0.75 (t, J = 7.38 Hz, 3H), 1.57 (m, 1H), 1.69 (m, 1H), 2.55 (s, 2H), 2.93 (m, 1H) , 7.04 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.0 Hz, 2H), 11.50 (s, 1H).

실시예 37. 3-(4-페녹시페닐)-4-(2-플루오르페닐)부타노익산(11)Example 37. 3- (4-phenoxyphenyl) -4- (2-fluorophenyl) butanoic acid (11)

3-(4-페녹시페닐)-3-히드록시-4-2(2-플루오르페닐)부타노익산 (실시예 24)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Was prepared from 3- (4-phenoxyphenyl) -3-hydroxy-4-2 (2-fluorophenyl) butanoic acid (Example 24) in the same manner as in Example 27.

수율: 77%,1H NMR(300 MHz, CDC13) δ 2.51(d, J=9.57 Hz, 2H), 2.92(m, 2H), 3.45(m, 1H), 6.72~7.42(m, 13H), 10.22(s, 1H). Yield: 77%, 1 H NMR ( 300 MHz, CDC1 3) δ 2.51 (d, J = 9.57 Hz, 2H), 2.92 (m, 2H), 3.45 (m, 1H), 6.72 ~ 7.42 (m, 13H) , 10.22 (s, 1 H).

실시예 38. 3-(4-페녹시페닐)-4-(3-플루오르페닐)부타노익산(12)Example 38. 3- (4-phenoxyphenyl) -4- (3-fluorophenyl) butanoic acid (12)

3-(4-페녹시페닐)-3-히드록시-4-(3-플루오르페닐)부타노에이트 (실시예 25)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Was prepared in the same manner as in Example 27 from 3- (4-phenoxyphenyl) -3-hydroxy-4- (3-fluorophenyl) butanoate (Example 25).

수율: 80%,1H NMR(300 MHz, CDC13) δ 2.65(m, 2H), 2.94(m, 2H), 3.35(m, 1H), 6.68~8.03(m, 13H), 10.78(s, 1H). Yield: 80%, 1 H NMR ( 300 MHz, CDC1 3) δ 2.65 (m, 2H), 2.94 (m, 2H), 3.35 (m, 1H), 6.68 ~ 8.03 (m, 13H), 10.78 (s, 1H).

실시예 39. 3-(4-페녹시페닐)-4-(4-플루오르페닐)부타노익산(13)Example 39. 3- (4-phenoxyphenyl) -4- (4-fluorophenyl) butanoic acid (13)

에틸 3-(4-페녹시페닐)-3-히드록시-4-(4-플루오르페닐)부타노에이트 (실시예 26)으로부터, 상기 실시예 27과 같은 방법에 의해 제조하였다.Prepared by the same method as in Example 27 from ethyl 3- (4-phenoxyphenyl) -3-hydroxy-4- (4-fluorophenyl) butanoate (Example 26).

수율: 85%,1H NMR(300 MHz, CDC13) δ 2.58(m, 2H), 2.91(m, 2H), 3.37(m, 1H), 6.78~7.35(m, 13H), 11.19(s, 1H). Yield: 85%, 1 H NMR ( 300 MHz, CDC1 3) δ 2.58 (m, 2H), 2.91 (m, 2H), 3.37 (m, 1H), 6.78 ~ 7.35 (m, 13H), 11.19 (s, 1H).

D. 항균 활성 시험D. Antimicrobial activity test

실시예 40. 시험관내 시험Example 40. In vitro testing

본 발명의 화학식 1의 화합물을 한천 평판 희석법으로 각각 50 및 200 ppm의 농도로 감자 한천 배치와 혼합하여 평판 배지를 제조하였다. 각 농도에 대해 10가지 식물 병균의 균종을 접종하고 27 ℃의 항온기에서 72 시간 배양한 후 약액이 첨가된 배지상의 균사 생육 저지율(%)를 조사하였다. 약액의 생물 활성도를 무처리구와 비교하여 다음 표 1에 나타내었다.Compounds of formula 1 of the present invention were mixed with batches of potato agar at concentrations of 50 and 200 ppm, respectively, by agar plate dilution method to prepare plate media. For each concentration, 10 kinds of mycorrhizal fungi were inoculated and cultured in a thermostat at 27 ° C for 72 hours. Mycelial growth inhibition rate (%) on the medium containing the drug solution was examined. The bioactivity of the drug solution is shown in Table 1 below in comparison with the untreated solution.

시험관내 시험결과In-vitro test results

[표 1] [Table 1]

실시예 41. 생체내 시험Example 41. In vivo test

- 벼 도열병 시험- rice blast test

사각 포트(16×7×7 ㎝)에 볍씨(품종: 추성)를 파종한 후, 21 일간 (4 엽기)육모하고, 상기 화학식 1의 화합물을 시험 농도별로 물에 희석하여 계면 활성제를 소량 첨가후 벼에 분무 처리하였다. 약제 처리 1일 후, 벼 도열병균의 포자 현탁액을 제조하여 적정량을 약제가 처리된 작물에 접종하여 접종상(온도: 29 ℃, 습도: RH 100%)에 48시간 동안 정치시킨 후 온실로 옮겨 벼 도열병을 발병시켰다. 균 접종 7일 후, 엽상의 병반수를 표기하고 무처리구와 비교하여 방제가를 산출함으로써 활성을 평가하였다.The seeds were seeded in a square pot (16 × 7 × 7 cm) and seeded with rice seeds (variety: Chusong) for 21 days (four leaves). The compound of formula (1) was diluted in water for each test concentration and a small amount of surfactant Rice were sprayed. One day after the medicament treatment, a spore suspension of rice blast fungus was prepared, and an appropriate amount of the spore suspension was inoculated to the medicinally treated crops and allowed to stand for 48 hours in an inoculation phase (temperature: 29 ° C, humidity: RH 100% It caused blast disease. Seven days after inoculation, the number of lesions on the leaf was noted, and the activity was evaluated by calculating the control value by comparing with the untreated control.

- 벼 문고병 시험- rice paperback test

사각 포트(16×7×7 ㎝)에 볍씨(품종: 추성) 10 립을 파종한 후, 21 일간 (4 엽기) 육모하고, 상기 화학식 1의 화합물을 시험 농도별로 물에 희석하여 계면 활성제를 소량 첨가한 후 벼에 분무 처리하였다. 약제 처리 1일 후, 벼 문고병의 접종원을 기주 식물이 육모된 가운데 부분에 놓고 가볍게 감아 접종상(온도: 29 ℃, 습도: RH 100%)에 72 시간 동안 정치시킨 후 온실에 옮겨 벼문고병을 발병시켰다. 균 접종 5일 후, 잎의 피해도를 산출하고 무처리구와 비교하여 방제가를 산출함으로써 활성을 평가하였다.10 seedlings were seeded in square pots (16 x 7 x 7 cm), and hair growth was carried out for 21 days (four leaves). The compound of formula (1) was diluted in water by the test concentration to prepare a small amount After the addition, rice was sprayed. One day after the chemical treatment, the inoculum of the rice paperback disease was placed on the central part of the plant where the host plants were raised, lightly wound and placed in the inoculation phase (temperature: 29 ° C, humidity: RH 100%) for 72 hours, transferred to the greenhouse, . After 5 days of inoculation, leaf damage was calculated, and the activity was evaluated by calculating the control value by comparing with the untreated control.

- 오이 흰 가루병 시험- Cucumber white powder bottle test

사각 포트(16×7×7 ㎝)에 오이 종자 2 립을 파종한 후, 15 일간(2~4 엽기) 육묘하고, 상기 화학식 1의 화합물을 시험 농도별로 물에 희석하여 계면 활성제를 소량 첨가한 후 오이 잎면에 분무 처리하였다. 약액 처리 1일 후, 오이 흰 가루병을 접종하여 온실(온도: 29 ℃)에서 10 일간 정치시켜 발병시켰다. 균 접종 10일 후 발병도를 산출하여 무처리구와 비교하여 방제가를 산출함으로써 활성을 평가하였다.Two seedlings of cucumber seeds were sown on square pots (16 × 7 × 7 cm) and seedlings were grown for 15 days (2 to 4 leafy days). The compound of formula (1) was diluted in water for each test concentration and a small amount of surfactant was added And sprayed on the leaf surface of cucumber. One day after the chemical solution treatment, cucumber white flour disease was inoculated and allowed to stand for 10 days in a greenhouse (temperature: 29 ° C). After 10 days of inoculation, the disease severity was calculated, and the activity was evaluated by calculating the control value by comparing with the untreated control.

- 토마토 역병균- tomato root bacillus

사각 포트(16×7×7 ㎝)에 토마토 2 립을 파종한 후, 25일간 (2~4 엽기)육묘하고, 상기 화학식 1의 화합물을 시험 농도별로 물에 희석하여 계면 활성제를 소량 첨가 후 토마토 잎면에 분무 처리하였다. 약액 처리 1일 후 토마토 역병균을 접종하여 온실(온도: 21 ℃)에서 5일간 정치시켜 발병시켰다. 균 접종 5일 후 발병도를 산출하여 무처리구와 비교하여 방제가를 산출함으로써 활성을 평가하였다.After seeding two ripos of tomatoes in a square pot (16 × 7 × 7 cm), the seedlings were cultivated for 25 days (2-4 days), and the compound of formula (1) was diluted with water according to the test concentration. The leaves were sprayed. One day after the chemical solution treatment, tomato rot fungus was inoculated and allowed to stand for 5 days in a greenhouse (temperature: 21 ° C). After 5 days of inoculation, the degree of disease was calculated, and the activity was evaluated by calculating the control value by comparing with the untreated control.

상기 생체내 시험 결과는 다음 표 2에 나타내었다.The in vivo test results are shown in Table 2 below.

생체내 시험 결과In vivo test results

[표 2] [Table 2]

본 발명에 의한 신규한 3, 4 치환된 부타노익산 유도체 (Ⅰ)은 살균 활성, 특히 벼도열병균, 오이흰가루 병균, 사과부패병균 등에 대한 살균 활성이 높고, 높은 수율로 간단히 합성할 수 있으며, 그에 따라 새로운 유도체를 합성하는 것이 용이하므로, 좀더 우수한 살균 활성을 갖는 유도체의 제조가 용이하게 이루어질 수 있을 것이라 기대된다.The novel 3, 4-substituted butanoic acid derivative (I) according to the present invention has a high bactericidal activity, in particular, a high bactericidal activity against rice blast fungus, cucumber powdery mildew, apple decay bacteria and the like, Therefore, it is expected that it is easy to synthesize a new derivative, so that it is expected that a derivative having more excellent fungicidal activity can be easily produced.

Claims (3)

다음 화학식 1을 갖는 3,4-디페닐부타노익산 유도체:A 3,4-diphenylbutanoic acid derivative having the following formula (1): < EMI ID = 화학식 1Formula 1 식 중, X는 할로겐 원소, 탄소 1~4개로 이루어진 알킬기, 메톡시기, 페녹시기 또는 브로모페닐기로 이루어진 군 중에서 선택된 것이며, Y는 탄소 1~4개로 이루어진 알킬기가 직접 치환되어 있거나, 탄소 1~4개로 이루어진 알킬기가 치환된 페닐기 또는 할로겐 원소가 치환된 페닐기임.Wherein X is selected from the group consisting of a halogen atom, an alkyl group of 1 to 4 carbon atoms, a methoxy group, a phenoxy group or a bromophenyl group, Y is an alkyl group of 1 to 4 carbon atoms, A phenyl group substituted with an alkyl group having 4 or a phenyl group substituted with a halogen atom. (a) 아세틸클로라이드 유도체와 치환된 벤젠을 디클로메탄 또는 1,2-디클로에탄 용매에 용해시켜 염화알루미늄을 첨가하여 반응시켜, 다음 화학식을 갖는 일차 중간체, 케톤 화합물을 제조하고,(a) dissolving an acetyl chloride derivative and substituted benzene in a solvent of dichloromethane or 1,2-dichloroethane and adding aluminum chloride to react to prepare a primary intermediate or ketone compound having the following formula, 식 중, X는 할로겐 원소, 탄소 1~4개로 이루어진 알킬기, 메톡시기, 페녹시기 또는 브로모페닐기로 이루어진 군 중에서 선택된 것이며, Y는 탄소 1~4개로 이루어진 알킬기가 직접 치환되어 있거나, 탄소 1~4개로 이루어진 알킬기가 직접 치환되어 있거나, 탄소 1~4개로 이루어진 알킬기가 치환된 페닐기 또는 할로겐 원소가 치환된 페닐기이고,Wherein X is selected from the group consisting of a halogen atom, an alkyl group of 1 to 4 carbon atoms, a methoxy group, a phenoxy group or a bromophenyl group, Y is an alkyl group of 1 to 4 carbon atoms, A phenyl group substituted with an alkyl group having 1 to 4 carbon atoms or a phenyl group substituted with a halogen atom, (b) 아연 가루와 요오드 촉매 존재 하에서, 상기 케톤 화합물과 에틸 브로모아세테이트를 벤젠, 리그로인 또는 그 혼합 용매에서 온도 80~100 ℃로 5~8 시간 반응시켜, 다음 화학식을 갖는 이차 중간체 에스테르 화학물을 제고하고,(b) reacting the ketone compound with ethyl bromoacetate in benzene, ligroin or a mixed solvent thereof at a temperature of 80 to 100 ° C for 5 to 8 hours in the presence of a zinc powder and an iodine catalyst to obtain a secondary intermediate ester chemical And, (c) 상기 이차 중간체, 에스테르 화합물을 디클로로메탄 용매에 용해시킨 후, 당량 또는 약간 과량의 트리에틸실란과 무수 황산 마그네슘을 첨가하고, 트리플루오르아세트산에 용해되어 있는 BF3·Et2O를 0~5 ℃의 온도를 유지하며 천천히 첨가한 후, 0~5 ℃를 유지하며 4~8 시간 교반시키며 반응시키는 것으로 이루어진, 다음 화학식 1을 갖는 3.4-디페닐부타노익산 유도체의 제조 방법:(c) dissolving the secondary intermediate or ester compound in a dichloromethane solvent, adding triethylsilane and anhydrous magnesium sulfate in an equivalent amount or a slight excess, adding BF 3揃 Et 2 O dissolved in trifluoroacetic acid to 0 - Diphenyl butanoic acid derivative having the following chemical formula 1, which is obtained by slowly adding water while keeping the temperature at 5 ° C, and maintaining the mixture at 0 to 5 ° C for 4 to 8 hours with stirring. 화학식 1Formula 1 식 중, X, Y 는 상기한 바와 같음.Wherein X and Y are as defined above. 다음 화학식 1을 갖는 3,4-디페닐부타노익산 유도체를 유효 성분으로 하는 살균제 조성물:Disinfectant composition comprising a 3,4-diphenylbutanoic acid derivative having the following formula (1) as an active ingredient: 화학식 1Formula 1 식 중, X는 할로겐 원소, 탄소 1~4개로 이루어진 알킬기, 메톡시기, 페녹시기 또는 브로모페닐기로 이루어진 군 중에서 선택된 것이며, Y는 탄소 1~4개로 이루어진 알킬기가 직접 치환되어 있거나, 탄소 1~4개로 이루어진 알킬기가 치환된 페닐기 또는 할로겐 원소가 치환된 페닐기임.Wherein X is selected from the group consisting of a halogen atom, an alkyl group of 1 to 4 carbon atoms, a methoxy group, a phenoxy group or a bromophenyl group, Y is an alkyl group of 1 to 4 carbon atoms, A phenyl group substituted with an alkyl group having 4 or a phenyl group substituted with a halogen atom.
KR1019970028271A 1997-06-27 1997-06-27 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition KR19990004221A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970028271A KR19990004221A (en) 1997-06-27 1997-06-27 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970028271A KR19990004221A (en) 1997-06-27 1997-06-27 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition

Publications (1)

Publication Number Publication Date
KR19990004221A true KR19990004221A (en) 1999-01-15

Family

ID=65987749

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970028271A KR19990004221A (en) 1997-06-27 1997-06-27 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition

Country Status (1)

Country Link
KR (1) KR19990004221A (en)

Similar Documents

Publication Publication Date Title
HU191529B (en) Fungicide and plant growth regulating compositions containing triazole derivatives as active substances and process for preparing the active substances
WO1995004054A1 (en) Pyrazole derivative
HUT60237A (en) N-(iodopropargyl oxycarbonyl)-amino acid ester derivatives, microbicidal compositions comprising such compounds as active ingredient and process for using the compounds and compositions
JP2788044B2 (en) Maleimide derivative and fungicide for agricultural and horticultural use containing the same as active ingredient
JPH0242801B2 (en)
US4875922A (en) Pyrimidine derivatives
JP2651933B2 (en) Fungicidal azolyl derivative
KR19990004221A (en) 3,4-Substituted Butanoic Acid Derivatives, Process for Producing the Same, and Fungicide Composition
JPH04297449A (en) N-hydroxybenzylguanidine derivative and germicide for agriculture and horticulture
KR100229440B1 (en) Novel propenoic ester and amide derivatives having a fluorovinyl group
WO2008104101A1 (en) 1-(3-methyl-4-fluoro) phenyl-1-methylcyclopropane compounds and use thereof
JPH07110833B2 (en) α-Substituted phenylacetic acid derivative
KR0123414B1 (en) Novel abscisic acid derivatives with fluorine
US3988328A (en) 5-Amino-2,3,7,8-tetrathiaalkane-1,9-dioic acids, esters and salts
KR970000684B1 (en) Imidazole derivatives process for preparing the same and fungicidal compositions comprising the derivative for agricultural and horticuttural uses
US5057145A (en) Phenylalkylimidazole compounds as fungicides
JPH021484A (en) 5,6-dihydro-1,4,2-dioxazine derivative and fungicide for agricultural and horticultural use
KR0119964B1 (en) Novel heterocyclic vinyl sulfide and sulfone compounds, and process for preparing the same
KR950004708B1 (en) Cyclohexane-1,3-dione derivative
KR0153801B1 (en) Novel vinylsulfide and vinylsulfon and process thereof
JPH03148267A (en) 1,2,4-oxadiazin-5-one derivative and agricultural and horticultural germicide
KR0126545B1 (en) New abscisic acid derivatives substituted by fluorine-growth regulators
JPH09255624A (en) Bicyclo(3.3.0)octane derivative
JPH075442B2 (en) Phenoxyalkylamines and agricultural and horticultural fungicides
JPS6024791B2 (en) Novel pyrone derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application